Recall Enforment Report D-0724-2021

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Noven Pharmaceuticals Inc, originally initiated on 07-30-2021 for the product Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186 The product was recalled due to failed stability specifications; out of specification for shear.. The product was distributed nationwide and the recall is currently ongoing.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0724-202107-30-202108-25-2021Class II223,382 boxesCombipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186Failed Stability Specifications; out of specification for shear.Ongoing
D-0725-202107-30-202108-25-2021Class II70,638 boxesCombipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186Failed Stability Specifications; out of specification for shear.Ongoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
68968-0514Combipatch (estradiol/norethindrone Acetate Transdermal System) Estradiol/norethindrone Acetate Transdermal SystemPatch, Extended ReleaseTransdermalNoven Therapeutics, LlcHuman Prescription Drug
68968-0525Combipatch (estradiol/norethindrone Acetate Transdermal System) Estradiol/norethindrone Acetate Transdermal SystemPatch, Extended ReleaseTransdermalNoven Therapeutics, LlcHuman Prescription Drug